# Cadila Pharmaceuticals Limited, Ahmedabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9

> Inspection records and compliance data for Cadila Pharmaceuticals Limited in Ahmedabad. 8 FDA inspections on record, 2 Form 483s, 1 warning letter, last inspected September 26, 2025.

---

## Details

- Name: Cadila Pharmaceuticals Limited
- FEI Number: 3007684569
- Business Operations: API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: 1389 Trasad Road, Dholka
- City: Ahmedabad
- Country Name: India
- Address: 1389 Trasad Road, Dholka, Ahmedabad, India
- Country: India

## Related Documents

- FDA Inspection 1293740 - Cadila Pharmaceuticals Limited - 2025-09-26 — source: FDA, date: September 26, 2025
- FDA Inspection 1293740 - Cadila Pharmaceuticals Limited - 2025-09-26 — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2025
- FDA Inspection 1205061 - Cadila Pharmaceuticals Limited - 2023-04-07 — classification: No Action Indicated (NAI), source: FDA, date: April 7, 2023
- FDA Inspection 1173461 - Cadila Pharmaceuticals Limited - 2022-06-17 — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2022
- FDA Inspection 1120482 - Cadila Pharmaceuticals Limited - 2020-02-14 — classification: No Action Indicated (NAI), source: FDA, date: February 14, 2020
- [FDA Inspection 1052117 - Cadila Pharmaceuticals Limited - 2018-05-03](https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/63f78d34-ad1d-4b85-87a0-067d7502a5cd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2018
- [FDA Inspection 1019141 - Cadila Pharmaceuticals Limited - 2017-07-14](https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/e9b41269-ccf9-440a-998d-71b03bdd1872) — source: FDA, date: July 14, 2017
- FDA Inspection 929697 - Cadila Pharmaceuticals Limited - 2015-05-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 15, 2015
- [WARNING_LETTER - Cadila Pharmaceuticals Limited - 2014-03-28](https://www.keypedia.com/records/warning_letter/cadila-pharmaceuticals-limited/e632d2bc-00bb-46bd-af88-c34895517e74) — source: FDA, date: March 28, 2014
- FDA Inspection 801838 - Cadila Pharmaceuticals Limited - 2012-09-21 — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2012

## Related Companies

- [Patheon Inc.](https://www.keypedia.com/companies/patheon-inc/76561a83-edb8-4c76-934b-6b2bd5e67949)
- [Lantheus Medical Imaging, Inc.](https://www.keypedia.com/companies/lantheus-medical-imaging-inc/6e9954f9-4df0-41b8-bad7-e8117a91ef76)
- [IBSA Institut Biochimique SA](https://www.keypedia.com/companies/ibsa-institut-biochimique-sa/b4d0cf36-d7bc-4ea3-851a-9b0efe59255e)
- [Merck Serono S.p.A.](https://www.keypedia.com/companies/merck-serono-spa/052a4b09-0189-4f5c-bdcc-33182a7d3488)
- [Fareva Richmond, Inc.](https://www.keypedia.com/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb)
- [Anesta LLC](https://www.keypedia.com/companies/anesta-llc/821f19a7-cabd-47ab-a635-7880a3c5046d)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5)
- [Watson Pharma Private Limited](https://www.keypedia.com/companies/watson-pharma-private-limited/846d9c2f-be10-415a-b681-5436e078ebfd)
- [Takeda GmbH, Plant Oranienburg](https://www.keypedia.com/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06)

## Related Officers

- [Thomas J. Cosgrove](https://www.keypedia.com/people/thomas-j-cosgrove/616abec3-5ed9-42aa-9f5d-392b5552b695)
